TP53 and neoplasm: The majority of the TP53 mutations result in single residue changes in p53 proteins, most of which – including the common “hot-spot” mutations – inactivate DNA-binding and tumor suppressor functions of wild-type (wt) p53, endowing mutant p53 proteins with transforming, gain-of-function (GOF) oncogenic properties [3–5].